References
- 1. PERNEFRI (Indonesian Society of Nephrology and Hypertension). Konsensus manajemen anemia pada penyakit ginjal kronik (Consensus on management of anemia in chronic kidney disease), 2011. Jakarta; 2011, p. 3-15.
- 2. BUTTARELLO M, PAJOLA R, NOVELO E, REBESCHINI M, GANTARO S, OLIOSI F, et al. Diagnosis of iron deficiency in patients undergoing hemodialysis. Am J Clin Pathol. 2010; 133:949-54.
- 3. CHUANG CL, LIU RS, WEI YH, HUANG TP, TARNG IC. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patient. Nephrol Dial Transplant. 2003; 18:370-7.
- 4. JAYARANEE S, STHANESHWAR P. RET-Y and RBC-Y in the diagnosis of iron deficiency associated with anemia of inflammation. Int. Jnl. Lab. Hem. 2010; 32:512-8.
- 5. WISH JB. Assessing iron status: Beyond serum ferritin and transferin saturation. Clin J Am Soc Nephrol. 2006; 1:S4-8.
- 6. BRUGNARA C, SCHILLER B, MORAN J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haem. 2006; 28:303-8.
- 7. KANEKO Y, MIYAZAKI S, HIRASAWA Y, GEJYO F, SUZUKI M. Transferin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients. Kidney Int. 2003; 63:1086-93.
- 8. MIWA N, AKIBA T, KIMATA H, HAMAGUCHI Y, AKARAWA Y, TAMURA T, et al. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of hemodialysis patients with iron deficiency. Int Jnl Lab Hem. 2010; 32:248-55.
- 9. NISSENSON AR, STROBOS J. Iron deficiency in patients with renal failure. Kidney International. 1999; 55:S18-21.
- 10. FISHBANE S, POLLACK S, FELDMAN HI, JOFFE MM. Iron indices in chronic kidney disease in the national health and nutritional examination survey 1988-2004. Clin J Am Soc Nephrol. 2009; 4:57-61.
- 11. HORI WH. Clinical aspects of iron use in the anemia of kidney disease. J Am Soc Nephrol. 2007; 18:382-93.
- 12. COYNE DW, KAPOIAN T, SUKI W, SINGH AK, MORAN JE, DAHL NU, et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum feritin and low transferrin saturation: Results of the dialysis patients’ response to IV iron with elevated ferritin (DRIVE) study. J Am Soc Nephrol. 2007; 18:975-84.
- 13. NKF-KDOQI. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006; 47: S28-70.
- 14. FRANK S, LINSSEN J, MESSINGER M, THOMAS L. Potensial utility of Ret-Y in the diagnosis of iron-Restricted erythropoesis. Clin Chem. 2004; 50:1240-2.
- 15. CANALS C, REMACHA AF, SARDA MP, PRAZUELO JM, ROYO MT, ROMERO A. Clinical utility of the new Sysmex XE 2100 parameter-reticulocyte hemoglobin equivalent in the diagnosis of anemia. The Hematology Journal. 2005; 90:1133-4.
- 16. GARZIA M, MARIO AD, FERRARO E, TAZZA L, ROSSI E., LICIANI G, et al. Reticulocyte Hemoglobin Equivalent: an indicator of reduced iron availability in chronic kidney disease during erytropoetin therapy. Lab Hem. 2007; 13:6-11.
- 17. MACONI M, CAVALCA L, DANISE P, CANDARELLI F, BRINI M. Erythrocyte and reticulocyte indices in iron deficiency in chronic kidney disease: comparison of two methods. The Scandinavian Journal of Clinical & Laboratory Investigation. 2009; 69:365-70.
- 18. URRECHAGA E, BORQUE L, ESCANERO JF. Analysis of reticulocyte parameters on the Sysmex XE 5000 and LH 750 analyzers in the diagnosis of inefficient erythropoiesis. Int J Lab Pathol. 2011; 33:37-44.